Sponsor of the Day:
Jerkmate
https://www.hikma.com/what-we-do/our-businesses/
Hikma | Global generic pharmaceutical company | Hikma
Hikma is a leading global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.
pharmaceutical companyhikmaglobalgeneric
https://insights.citeline.com/generics-bulletin/business/strategy/hikma-abandons-503b-compounding-and-strikes-fresh-inhalers-deal-ONUJSLJWUFFALHVFVASGAUSXLA/
Hikma Abandons 503B Compounding And Strikes Fresh Inhalers Deal
Apr 27, 2026 - Recently-reinstalled Hikma CEO Said Darwazah is wasting no time in taking action to turn the business around and restore focus, bringing to an end the...
hikmaabandons503bcompoundingstrikes
https://www.hikma.com/investors/investor-tools/investment-calculator/
Investment calculator | Hikma
investment calculatorhikma
https://endpoints.news/hikma-vs-amarin-generic-drug-case-heads-to-supreme-court-arguments/
Hikma and Amarin’s generic drug case heads to Supreme Court arguments
Apr 28, 2026 - When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the entire generic drug industry will be watching.
supreme court argumentsgeneric drugcase headshikma
https://www.hikma.com/investors/
Investor Relations | Hikma Pharmaceuticals | Hikma
Parnter with Hikma pharmaceuticals for high-quality injectable, oral and respiratory manufacturing expertise. With 29 manufacturing plants, we ensure that your...
investor relationshikmapharmaceuticals
https://www.hikma.com/investors/why-invest/
Why invest | Hikma
investhikma
https://thetimesofuae.com/hikma-reiterates-full-year-2026-guidance-following-encouraging-start-to-the-year/
Hikma reiterates full year 2026 guidance following encouraging start to the year - News Magazine...
Apr 23, 2026 - Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General...
full year2026 guidancenews magazinehikmareiterates